Table 2.
Outcome | Events N (%) |
Crude | Model 1* | Model 2† | |||
---|---|---|---|---|---|---|---|
HR (95% CI) |
P-value | HR (95% CI) |
P-value | HR (95% CI) |
P-value | ||
Heart failure hospitalization or death‡ | |||||||
• No pulmonary hypertension | 52 (21) | 1.0 (ref) | — | 1.0 (ref) | — | 1.0 (ref) | — |
• Pulmonary hypertension present | 28 (47) | 2.19 (1.36, 3.53) | 0.001 | 2.18 (1.20, 3.70) | 0.003 | 1.84 (1.09, 3.10) | 0.02 |
Model 1 adjusted for age, sex, diabetes mellitus, estimated glomerular filtration rate, and ejection fraction.
Model 2 adjusted for b-type natriuretic peptide in addition to covariates in model 1.
Because of missing data on heart failure hospitalization (N=106), the total N for this analysis is 302 (242 in the no PH group and 60 in the PH group). Please see method sections for more details.
HR, hazard ratio; CI, confidence interval.